Internal Medicine · Los Angeles, CA
NPI
1871546333
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1300 N Vermont Ave, Suite 806
Los Angeles, CA, 90027
Phone (323) 660-5191
Groups this clinician bills Medicare through
Medicare paid, 2024
$321K
5,497 services
Medicare patients, 2024
627
Average age 75
Drug cost, 2024
$3.2M
33,104 prescriptions
Company payments, 2025
$573
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Krikor I Kalindjian was code 99232 (hospital e&m - subsequent), 1,128 times for 182 patients. In total Krikor I Kalindjian billed 5,497 services in 24 codes, and Medicare paid $321K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,128 | 182 | $55.85 | $63K |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 934 | 301 | $23.15 | $22K |
| 99214 Office E&M - Established | Office | 798 | 308 | $86.85 | $69K |
| 82947 Clinical Chemistry | Office | 465 | 166 | $3.85 | $1,790 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 401 | 123 | $35.52 | $14K |
| 99349 Home E&M - New and Established | Office | 343 | 38 | $87.40 | $30K |
| 99223 Hospital E&M - Initial | Facility | 285 | 223 | $122.61 | $35K |
| 99233 Hospital E&M - Subsequent | Facility | 203 | 43 | $84.22 | $17K |
| 99309 SNF E&M | Facility | 194 | 52 | $75.43 | $15K |
| 99238 Hospital Discharge Management | Facility | 192 | 159 | $58.06 | $11K |
| 99213 Office E&M - Established | Office | 129 | 102 | $53.94 | $6,958 |
| 99308 SNF E&M | Facility | 115 | 35 | $53.62 | $6,167 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 100 | 100 | $121.10 | $12K |
| 99306 SNF E&M | Facility | 44 | 42 | $124.30 | $5,469 |
| 99215 Office E&M - Established | Office | 36 | 35 | $129.76 | $4,671 |
By year: 2022 $354K for 6,094 services; 2023 $357K for 6,061 services; 2024 $321K for 5,497 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 465 | 166 | $3.85 | $1,790 |
Medicare prescription drug claims, 2024
In 2024, the drug Krikor I Kalindjian prescribed most often to Medicare patients was Amlodipine Besylate, with 1,191 prescriptions and refills. In total Krikor I Kalindjian wrote 33,104 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,191 | 1,356 | 166 | $4,087 |
| Atorvastatin Calcium Generic | 1,096 | 1,223 | 174 | $7,136 |
| Rosuvastatin Calcium Generic | 822 | 953 | 95 | $3,514 |
| Omeprazole Generic | 740 | 785 | 90 | $3,819 |
| Lisinopril Generic | 690 | 803 | 88 | $1,655 |
| Gabapentin Generic | 684 | 729 | 77 | $5,354 |
| Clonidine Hcl Generic | 668 | 681 | 90 | $1,736 |
| Metformin Hcl Generic | 640 | 777 | 81 | $2,512 |
| Tamsulosin Hcl Generic | 606 | 629 | 73 | $3,889 |
| Vascepa Icosapent Ethyl | 580 | 604 | 69 | $191K |
| Furosemide Generic | 553 | 591 | 98 | $1,836 |
| Levothyroxine Sodium Generic | 551 | 624 | 76 | $2,670 |
| Carvedilol Generic | 504 | 575 | 90 | $2,260 |
| Pantoprazole Sodium Generic | 502 | 565 | 87 | $5,824 |
| Metoprolol Succinate Generic | 476 | 506 | 60 | $2,661 |
Brand drugs: 5,872 claims; generic drugs: 26,671 claims; opioid claims: 720.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Krikor I Kalindjian $573 ($573 in general payments such as food, travel and fees) from 10 companies. The largest payer was Ardelyx, Inc. with $165.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 5 | $165 |
| Lilly USA, LLC LLY | 4 | $128 |
| Amgen Inc. AMGN | 2 | $65.38 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $55.4 |
| Paratek Pharmaceuticals, Inc. | 2 | $45.66 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $28.63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27.85 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.16 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $15.85 |
| Scilex Pharmaceuticals Inc. | 1 | $14.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.